Colinz Laboratories approves reappointment of CEO and director at 40th AGM
- Colinz Laboratories held its 40th AGM on September 22, 2026
- Members adopted audited financial statements for FY26
- N.K. Menon reappointed as Whole Time Director and CEO
- Vijaya Mani appointed as Non-Executive Non-Independent Director

*this image is generated using AI for illustrative purposes only.
Colinz Laboratories Limited held its 40th Annual General Meeting on September 22, 2026. The meeting focused on the adoption of financial statements for FY26 and key governance changes, including the reappointment of leadership figures.
The proceedings were conducted via Video Conferencing or Other Audio Video Means (OAVM). Mrs. Vijaya Mani served as the Chairperson of the meeting. She confirmed the presence of a quorum and acknowledged the sad demise of Late Dr. Mani L.S., the Founder Director and Promoter, during the financial year.
Key resolutions approved
The Board commended several items of business for member approval, covering both ordinary and special business. The audited financial statements for the year ended March 31, 2026, along with the reports of the Board of Directors and Auditors, were adopted.
| Resolution | Type | Details |
|---|---|---|
| Adoption of Financial Statements | Ordinary | For the year ended March 31, 2026 |
| Reappointment of Director | Ordinary | Mr. N. K. Menon (DIN-01111297) retiring by rotation |
| Appointment of Director | Ordinary | Mrs. Vijaya Mani (DIN: 11363910) as Non-Executive Non-Independent Director |
| Reappointment of CEO | Special | Mr. N. K. Menon as Whole Time Director & Chief Executive Officer |
Governance updates
Mr. N. K. Menon, who serves as the Whole Time Director and Chief Executive Officer, was reappointed following his retirement by rotation. Additionally, members approved his continued remuneration package through a special resolution. Mrs. Vijaya Mani was formally appointed as a Director in her capacity as a Non-Executive Non-Independent Director.
The meeting concluded at 3:03 pm after the Chairperson informed members that the results of the e-voting would be reconciled by the Scrutinizer, M/s. Ashwini Vaze & Associates. The final report is scheduled to be made available on the company website and relevant stock exchange platforms within 48 hours.
Historical Stock Returns for Colinz Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.21% | +3.26% | +0.89% | +62.77% | +84.02% | +300.32% |
How will the transition of leadership following the demise of Founder Dr. Mani L.S. impact Colinz Laboratories' long-term strategic direction and R&D pipeline?
What specific growth initiatives or market expansions are expected to be prioritized under Mr. N. K. Menon's renewed tenure as CEO?
How might the formal appointment of Mrs. Vijaya Mani as a Non-Executive Non-Independent Director influence the company's corporate governance standards and investor confidence?

































